Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 2204 composition records across product categories including Cleaning products and household care, Industrial products, Laboratory supplies.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 (low) · high confidence.
Prevalence of HYDROCHLORIC ACID in our catalog (epa_cpdat).
Products
2,204
Brands
6
Typical roles
Catalog
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 2204 composition records across product categories including Cleaning products and household care, Industrial products, Laboratory supplies. EPA CPDat classifies this chemical for functional uses including pH regulating agent, Cleaning agent, Anti-scaling agent.
US
FDA
Route: AURICULAR (OTIC); Dosage form: SOLUTION; Potency: 0.37 %w/v
US
FDA
Anti-Dandruff Shampoo
Nizoral
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Route: AURICULAR (OTIC); Dosage form: SOLUTION/ DROPS; Potency: ADJ PH
US
FDA
Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: 0.04 %w/v
US
FDA
Route: AURICULAR (OTIC); Dosage form: SUSPENSION/ DROPS; Potency: ADJ PH
US
FDA
Route: DENTAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: ENDOTRACHEAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: ENDOTRACHEAL; Dosage form: POWDER, FOR SUSPENSION; Potency: ADJ PH
US
FDA
Route: EPIDURAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: EPIDURAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
US
FDA
Route: EPIDURAL; Dosage form: SOLUTION; Potency: ADJ PH
US
FDA
Route: EXTRACORPOREAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: EXTRACORPOREAL; Dosage form: SOLUTION; Potency: ADJ PH
US
FDA
Route: INFILTRATION; Dosage form: INJECTION; Potency: 0.37 %w/v
US
FDA
Route: INFILTRATION; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
US
FDA
Route: INTERSTITIAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRA-AMNIOTIC; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRA-ARTERIAL; Dosage form: INJECTION; Maximum daily exposure: 840 mg
US
FDA
Route: INTRA-ARTERIAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRA-ARTERIAL; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRA-ARTERIAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRA-ARTERIAL; Dosage form: SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRA-ARTICULAR; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRA-ARTICULAR; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH
US
FDA
Route: INTRABURSAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRACARDIAC; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRACARDIAC; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRACAUDAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRACAUDAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRACAVERNOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRACAVITARY; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRACAVITARY; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRADERMAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRADERMAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRALESIONAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRALESIONAL; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 306 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, EMULSION; Potency: ADJ PH
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 1037 mg
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION, CONCENTRATE; Potency: ADJ PH
US
FDA
Route: INTRAMUSCULAR; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH
US
FDA
Route: INTRAMUSCULAR; Dosage form: LIQUID; Potency: ADJ PH
US
FDA
Route: INTRAMUSCULAR; Dosage form: SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRAMUSCULAR; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: 5 mg
US
FDA
Route: INTRAOCULAR; Dosage form: INJECTION, SOLUTION, CONCENTRATE; Potency: ADJ PH
US
FDA
Route: INTRAOCULAR; Dosage form: SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRAPERITONEAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRAPERITONEAL; Dosage form: SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRAPLEURAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRASPINAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRASYNOVIAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRASYNOVIAL; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH
US
FDA
Route: INTRATHECAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRATHECAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRATHECAL; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRATHECAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRATHECAL; Dosage form: SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRATUMOR; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRATUMOR; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRATYMPANIC; Dosage form: SUSPENSION; Maximum daily exposure: 1 mg
US
FDA
Route: INTRAVASCULAR; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRAVASCULAR; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRAVASCULAR; Dosage form: SOLUTION; Potency: ADJ PH
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTABLE, LIPOSOMAL; Potency: ADJ PH
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 720 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Potency: ADJ PH
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: 0.18 %w/v
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Potency: 4.17 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: 160 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 1037 mg
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION, CONCENTRATE; Potency: ADJ PH
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, SUSPENSION, LIPOSOMAL; Potency: ADJ PH
US
FDA
Route: INTRAVENOUS; Dosage form: LIQUID; Potency: ADJ PH
US
FDA
Route: INTRAVENOUS; Dosage form: POWDER; Potency: ADJ PH
US
FDA
Route: INTRAVENOUS; Dosage form: SOLUTION; Potency: 18.25 mg
US
FDA
Route: INTRAVENOUS; Dosage form: SOLUTION, CONCENTRATE; Potency: ADJ PH
US
FDA
Route: INTRAVESICAL; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 157 mg
US
FDA
Route: INTRAVITREAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: INTRAVITREAL; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH
US
FDA
Route: IONTOPHORESIS; Dosage form: SOLUTION; Potency: ADJ PH
US
FDA
Route: IRRIGATION; Dosage form: SOLUTION; Potency: ADJ PH
US
FDA
Route: NASAL; Dosage form: SOLUTION; Potency: 91.7 mg/100ml
US
FDA
Route: NASAL; Dosage form: SPRAY, METERED; Potency: ADJ PH
US
FDA
Route: NASAL; Dosage form: SUSPENSION; Potency: ADJ PH
US
FDA
Route: OPHTHALMIC; Dosage form: EMULSION; Potency: ADJ PH
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.31 %w/v
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: ADJ PH
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: ADJ PH
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: ADJ PH
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 7 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Potency: ADJ PH
US
FDA
Route: ORAL; Dosage form: CONCENTRATE; Potency: 2.17 mg/1ml
US
FDA
Route: ORAL; Dosage form: LIQUID; Potency: 4.46 mg/1ml
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 125 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 223 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: ADJ PH
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 24 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: ADJ PH
US
FDA
Route: PARENTERAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: PARENTERAL; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH
US
FDA
Route: PARENTERAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
US
FDA
Route: PERIDURAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: PERINEURAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: AEROSOL, METERED; Potency: 0.7 %w/w
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: AEROSOL, SPRAY; Potency: 1.5 %w/w
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: SOLUTION; Potency: ADJ PH
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: SPRAY; Potency: ADJ PH
US
FDA
Route: RETROBULBAR; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: SOFT TISSUE; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: SOFT TISSUE; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH
US
FDA
Route: SUBARACHNOID; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
US
FDA
Route: SUBCONJUNCTIVAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, EMULSION; Potency: ADJ PH
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Potency: ADJ PH
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Potency: ADJ PH
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 1037 mg
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION, CONCENTRATE; Potency: ADJ PH
US
FDA
Route: SUBCUTANEOUS; Dosage form: INJECTION, SUSPENSION; Potency: ADJ PH
US
FDA
Route: SUBCUTANEOUS; Dosage form: SOLUTION; Potency: ADJ PH
US
FDA
Route: SUBCUTANEOUS; Dosage form: SUSPENSION; Potency: ADJ PH
US
FDA
Route: SUBCUTANEOUS; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: 5 mg
US
FDA
Route: SUBMUCOSAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: SUBMUCOSAL; Dosage form: INJECTION, SOLUTION; Potency: ADJ PH
US
FDA
Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: ADJ PH
US
FDA
Route: TOPICAL; Dosage form: EMULSION; Potency: ADJ PH
US
FDA
Route: TOPICAL; Dosage form: SHAMPOO; Maximum daily exposure: 104 mg
US
FDA
Route: TOPICAL; Dosage form: SOLUTION; Potency: ADJ PH
US
FDA
Route: TOPICAL; Dosage form: SOLUTION/ DROPS; Potency: ADJ PH
US
FDA
Route: TOPICAL; Dosage form: SUSPENSION/ DROPS; Potency: ADJ PH
US
FDA
Route: URETERAL; Dosage form: SOLUTION; Potency: ADJ PH
US
FDA
Route: URETHRAL; Dosage form: INJECTION; Potency: ADJ PH
US
FDA
Route: URETHRAL; Dosage form: SOLUTION; Potency: ADJ PH
US
FDA
FDA NDC lists this ingredient in 35 active drug products and 37 total products.
US
FDA
openFDA substance registry classifies this ingredient as concept.
US
FDA
openFDA substance registry classifies this ingredient as chemical.